Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 73.0% to $0.4585 on volume of 640,087,036 shares Ocean Power Technologies Inc. (OPTT) rose 34.9% to $0.1812 on volume of 396,326,565 shares NVIDIA Corporation (NVDA) rose 0.2% to $1...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 6.8% to $126.09 on volume of 414,790,976 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 18.7% to $0.265 on volume of 162,165,405 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) fell 12.6%...
2024-06-25 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for ALNY on June 25, 2024 08:02AM ET. The previous analyst recommendation was Outperform. ALNY was trading at $222.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-06-25 09:00:09 ET Luca Issi from RBC Capital issued a price target of $250.00 for ALNY on 2024-06-25 07:39:00. The adjusted price target was set to $250.00. At the time of the announcement, ALNY was trading at $222.9. The overall price target consensus is at $220.72...
2024-06-25 09:00:09 ET Liisa Bayko from Evercore ISI issued a price target of $260.00 for ALNY on 2024-06-25 08:02:00. The adjusted price target was set to $260.00. At the time of the announcement, ALNY was trading at $222.9. The overall price target consensus is at $220...
2024-06-25 07:30:02 ET Wells Fargo analyst issues EQUAL-WEIGHT recommendation for ALNY on June 25, 2024 06:34AM ET. The previous analyst recommendation was Equal-Weight. ALNY was trading at $222.9 at issue of the analyst recommendation. The overall analyst consensus : BU...
2024-06-25 07:15:05 ET Citigroup analyst issues BUY recommendation for ALNY on June 25, 2024 05:57AM ET. The previous analyst recommendation was Buy. ALNY was trading at $222.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...
2024-06-25 06:45:00 ET Summary Alnylam has been extremely persistent over the years in getting their RNA interference ideas developed and tested. That original RNAi therapy (patisiran) was directed towards neuropathy, but Alnylam has been hoping that such treatments would show ben...
2024-06-25 05:15:02 ET Barclays analyst issues OVERWEIGHT recommendation for ALNY on June 25, 2024 04:48AM ET. The previous analyst recommendation was Overweight. ALNY was trading at $222.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-06-24 18:30:03 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for ALNY on June 24, 2024 04:25PM ET. The previous analyst recommendation was Equal-Weight. ALNY was trading at $222.9 at issue of the analyst recommendation. The overall analyst consensus :...
News, Short Squeeze, Breakout and More Instantly...
Alnylam Pharmaceuticals Inc. Company Name:
ALNY Stock Symbol:
NASDAQ Market:
Alnylam Pharmaceuticals Inc. Website:
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2024 on Thursday, August 1, 2024, before the U.S. financial markets open. Management will provide an update on th...
2024-06-29 16:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...